Business - Briefly   

ABL Biotech signs MoU with U.S. firm

CHENNAI: ABL Biotechnologies has signed a memorandum of understanding (MoU) with U.S.-based PR Pharmaceuticals for jointly working on novel drug delivery systems. The initial work will be in the areas of liposome and microphere-based drug delivery, says a release. — Corporate Reporter

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Sub-accounts free to invest in ODIs
Oracle opens two new units
Adobe plans to strike IT ‘rich’
OIL plans IPO in 2008
‘Wellness’ stores from Reliance Retail
LIC launches group insurance product
Bank of America plans to cut 3,000 jobs
ICBC to acquire 20 p.c. of S. Africa’s Standard Bank
JSW Steel to expand Vijayanagar unit capacity
ITC to develop spices in north-east
Sensex jumps 258 points
Exchange Rates
Bullion Rates
DoT to issue LoI to Idea, Verizon
Hindustan Zinc cuts zinc, lead prices
CLB seeks report from Bajaj brothers
Indian Steel moves Supreme Court
FIIs buy shares worth Rs. 100 cr.
Varun Industries enters market with IPO
IBS opens campus in Thiruvananthapuram
ABL Biotech signs MoU with U.S. firm
Hindustan Motors reports profit
Literoof Housing inaugurates plant
PremierLife Pension from ICICI Prudential
Super Salary Account from Union Bank

Copyright © 2007, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu